Systemic and iatrogenic factors contribute to the development of severe hypernatraemia in vulnerable inpatients
Clinical Endocrinology · 2024
DOI: 10.1111/cen.14978 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Clinical Endocrinology, 2024. Verfasst von Esha Kathpal und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology & Diabetes, Western Health, Victoria, Australia. Hauptthemen laut MEDLINE: Hypernatremia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objectives
To determine all‐cause in‐hospital mortality associated with severe hypernatraemia and the causes, comorbidities, time to treatment, discharge destination and postdischarge mortality.
Design
Retrospective observational cohort study. Patients Severe hypernatraemia, (sodium concentration ≥ 155 mmol/L), at any time during a tertiary hospital admission in Melbourne, Australia, 1 January 2019 to 31 December 2019 (pre‐COVID19).
Measurements
Deaths, Charlson Comorbidity Index (CCI), hypernatraemia causes, time to treatment, discharge destination.
Results
One hundred and one inpatients: 64 community‐acquired, 37 hospital‐acquired. In‐hospital mortality was 38%, but cumulative mortality was 65% by 1 month after discharge, with only a minor further increase at 6 and 12 months. After adjusting for peak sodium concentration, the community acquired group had significantly reduced odds of in‐hospital mortality (odds ratio 0.15, 95% confidence interval [0.04−0.54], p = .003). Iatrogenic factors were present in 57% (21/37) of the hospital‐acquired group. Only 55% of all cases received active sodium directed treatment. Time to start treatment did not affect outcomes. High levels of comorbidity were present, median CCI (IQR) was 6 (5−8) in the community and 5 (4−7) in the hospital group. Dementia prevalence was higher in the community group, 66% (42/64) versus 19% (7/37) ( p = .001). Infection was the most common precipitant with 52% (33/64) in the community and 32% (12/37) in the hospital group. Of the survivors, 32% who had been living independently required residential care after discharge.
Conclusions
Mortality was high and loss of independence in survivors common. To potentially improve outcomes, hypernatraemia‐specific guidelines should be formulated and efforts made to reduce system and iatrogenic factors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology & Diabetes, Western Health, Victoria, Australia.
- Department of Medicine, Western Health, University of Melbourne, Victoria, Australia.
ORCID-Profile: Esha Kathpal, Emma Boehm, Christopher S Nguyen, Sara Vogrin, Peter S Hamblin
Zitieren
APA
Kathpal, E., Boehm, E., Nguyen, C. S., Vogrin, S., & Hamblin, P. S. (2024). Systemic and iatrogenic factors contribute to the development of severe hypernatraemia in vulnerable inpatients. Clinical Endocrinology. https://doi.org/10.1111/cen.14978
Vancouver
Kathpal E, Boehm E, Nguyen CS, Vogrin S, Hamblin PS. Systemic and iatrogenic factors contribute to the development of severe hypernatraemia in vulnerable inpatients. Clinical Endocrinology. 2024. doi:10.1111/cen.14978
BibTeX
@article{Kathpal2024,
author = {Kathpal, Esha and Boehm, Emma and Nguyen, Christopher S and Vogrin, Sara and Hamblin, Peter S},
title = {Systemic and iatrogenic factors contribute to the development of severe hypernatraemia in vulnerable inpatients},
journal = {Clinical Endocrinology},
year = {2024},
doi = {10.1111/cen.14978}
}
EUVIMED